Company page

Summit Therapeutics Inc.

Summit Therapeutics Inc. is a public company traded under the ticker SMMT in the American market. The company has a market capitalization of approximately $10.67 billion. Summit Therapeutics focuses on developing innovative therapies for various diseases.

profileSMMT:NASDAQAI content: aiUpdated June 24, 2026/company/summit-therapeutics-plc/c-ffucsxvp
Summit Therapeutics Inc. logo
Ticker
SMMT:NASDAQ
Asset type
Stock
Market cap
$10.67B
Sector
Health Technology
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD